Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lin

Showing results (711-720 of 792) with videos related to

Pageof 80
Sort By:
American Journal of Obstetrics and Gynecology|April 9, 2008
Impact of vessel maturation on antiangiogenic therapy in ovarian cancerChunhua Lu, Premal H Thaker, Yvonne G Lin, et al.
Scientific Reports|March 28, 2019
Strain effect on orbital and magnetic structures of Mn ions in epitaxial Nd<sub>0.35</sub>Sr<sub>0.65</sub>MnO<sub>3</sub>/SrTiO<sub>3</sub> films using X-ray diffraction and absorptionY C Shao, N G Deshpande, Y Y Chin, et al.
Cancer Research|October 3, 2007
Antitumor and antivascular effects of AVE8062 in ovarian carcinomaTae Jin Kim, Murali Ravoori, Charles N Landen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2019
Correction: Focal Adhesion Kinase Targeting Using <i>In vivo</i> Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma TherapyJyotsnabaran Halder, Aparna A Kamat, Charles N Landen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapyJyotsnabaran Halder, Aparna A Kamat, Charles N Landen, et al.
Nature Genetics|February 9, 2021
Acute BAF perturbation causes immediate changes in chromatin accessibilitySandra Schick, Sarah Grosche, Katharina Eva Kohl, et al.
Gynecologic Oncology|March 30, 2024
The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 studyPaulette Mhawech-Fauceglia, Denis McCarthy, Akiko Tonooka, et al.
Cancer Research|July 18, 2008
Clinical and biological significance of tissue transglutaminase in ovarian carcinomaJee Young Hwang, Lingegowda S Mangala, Jansina Y Fok, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2017
Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosisJ-Y Feng, L G Jarlsberg, K Salcedo, et al.
Molecular Cancer Therapeutics|April 8, 2010
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancerWilliam M Merritt, Alpa M Nick, Amy R Carroll, et al.
Pageof 80

Showing results (711-720 of 792) with videos related to

Sort By:
Pageof 80
American Journal of Obstetrics and Gynecology|April 9, 2008
Impact of vessel maturation on antiangiogenic therapy in ovarian cancerChunhua Lu, Premal H Thaker, Yvonne G Lin, et al.
Scientific Reports|March 28, 2019
Strain effect on orbital and magnetic structures of Mn ions in epitaxial Nd<sub>0.35</sub>Sr<sub>0.65</sub>MnO<sub>3</sub>/SrTiO<sub>3</sub> films using X-ray diffraction and absorptionY C Shao, N G Deshpande, Y Y Chin, et al.
Cancer Research|October 3, 2007
Antitumor and antivascular effects of AVE8062 in ovarian carcinomaTae Jin Kim, Murali Ravoori, Charles N Landen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2019
Correction: Focal Adhesion Kinase Targeting Using <i>In vivo</i> Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma TherapyJyotsnabaran Halder, Aparna A Kamat, Charles N Landen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapyJyotsnabaran Halder, Aparna A Kamat, Charles N Landen, et al.
Nature Genetics|February 9, 2021
Acute BAF perturbation causes immediate changes in chromatin accessibilitySandra Schick, Sarah Grosche, Katharina Eva Kohl, et al.
Gynecologic Oncology|March 30, 2024
The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 studyPaulette Mhawech-Fauceglia, Denis McCarthy, Akiko Tonooka, et al.
Cancer Research|July 18, 2008
Clinical and biological significance of tissue transglutaminase in ovarian carcinomaJee Young Hwang, Lingegowda S Mangala, Jansina Y Fok, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2017
Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosisJ-Y Feng, L G Jarlsberg, K Salcedo, et al.
Molecular Cancer Therapeutics|April 8, 2010
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancerWilliam M Merritt, Alpa M Nick, Amy R Carroll, et al.
Pageof 80